Ratio of oestradiol concentration on the day of human chorionic gonadotrophin administration to mid-luteal oestradiol concentration is predictive of in-vitro fertilization outcome
Fi. Sharara et Hd. Mcclamrock, Ratio of oestradiol concentration on the day of human chorionic gonadotrophin administration to mid-luteal oestradiol concentration is predictive of in-vitro fertilization outcome, HUM REPR, 14(11), 1999, pp. 2777-2782
The role of luteal oestradiol for successful implantation in humans seems t
o be permissive rather than obligatory. Few studies have attempted to clari
fy the role of early luteal oestradiol in in-vitro fertilization (IVF) outc
ome, whether peri-implantation oestradiol is predictive of successful IVF o
utcome. We retrospectively analysed 106 women undergoing 106 IVF/embryo tra
nsfer cycles. Only the first treatment cycle per patient was analysed. Peak
oestradiol denoted the concentration on the day of human chorionic gonadot
rophin (HCG) administration. Mid-luteal oestradiol was obtained 3 days afte
r embryo transfer (8 days after HCG administration). A total of 44 pregnanc
ies were noted (41.51%), There were no differences in age, cycle day 3 foll
icle stimulating hormone (FSH), peak oestradiol, number of retrieved oocyte
s, number of embryo transfers, and mid-luteal oestradiol between pregnant a
nd non-pregnant women. However, the ratio of day of HCG oestradiol to mid-l
uteal oestradiol was highly predictive of successful outcome: the ongoing p
regnancy rate and implantation rate (sacs with fetal heart beat/embryo tran
sfer) were 15.8 and 5.7% respectively if the above ratio exceeded 5.0 (n =
19), compared to 42.1 and 16.3%, and 53.3 and 26.5% if the ratio was betwee
n 0.4 and 2.5 (n = 57), and between 2.5 and 5.0 (n = 30) respectively, Our
study suggests that the magnitude of decline in oestradiol concentrations a
fter oocyte retrieval may be important in predicting IVF success. We postul
ate that endometrial integrity may become compromised when a dramatic drop
in oestradiol occurs by the mid-luteal period. Whether these women benefit
from oestradiol supplementation after oocyte retrieval remains to be invest
igated.